Spyre Therapeutics
spyretherapeutics.com
Actively hiring
Immunology & Inflammation Therapeutics
Biologics & Biosimilars
Follow
Overview
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$390M
2 rounds on record
Latest round
$180M
Venture round · Dec 2023 · 2 yr ago
Team
102
US Form 5500 (plan participants) · Dec 2025 · +52% in a year
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team of 102 was 67 · US Form 5500 (plan participants)
Dec 11, 2023
Raised a round Venture round $180M · SEC Form D
Jun 26, 2023
Raised a round Venture round $210M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2023 | $180M | — | SEC Form D |
| Venture round | Jun 2023 | $210M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Spyre Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Cameron TurtleExecutive Officer, DirectorSEC Form D
Scott BurrowsExecutive OfficerSEC Form D
Heidy King-JonesExecutive OfficerSEC Form D
Jonathan AlspaughExecutive OfficerSEC Form D
Cortney CaudillExecutive OfficerSEC Form D
Overview
Spyre Therapeutics is a clinical-stage biotechnology company developing next-generation antibody therapies in immunology. Its pipeline includes extended half-life antibodies against targets such as TL1A and IL-23 as well as combination programs. The company is headquartered in Waltham, Massachusetts, United States.
Tech stack
Technologies named in job postings at Spyre Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
2
Stack modernity
50/100
Languages
SAS
Cloud & platforms
GCP
Developer tools
Microsoft Excel
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$312k
Typical range
$198k – $398k
Open positions
5
5
Jobs
Senior
40%
Architect
60%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 2 | $313k | $312k – $314k |
| Architect | 3 | $311k | $198k – $398k |
Highest paying role
Vice President, Clinical Development
$398k
Normalized to USD per year
All salaries at Spyre Therapeutics
By role, level and city, against the market · 5 jobs with pay
People
Cameron Turtle
Executive Officer, Director
Scott Burrows
Executive Officer
Heidy King-Jones
Executive Officer
Jonathan Alspaugh
Executive Officer
Cortney Caudill
Executive Officer
Tomas Kiselak
Director
Laurie Stelzer
Director
Russell Cox
Director
Peter Harwin
Director
Alison Lawton
Director
Michael Henderson
Director
Jeffrey Albers
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
56/100
Growing
Open positions
6
1 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
10/16/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
50% ▼
Operations
17% ▲
Science & Research
17% ▲
Industrial Engineering
17% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Waltham
United States
HQ